Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Retinal Drugs and Biologics
1.2 Key Market Segments
1.2.1 Retinal Drugs and Biologics Segment by Type
1.2.2 Retinal Drugs and Biologics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Retinal Drugs and Biologics Market Overview
2.1 Global Market Overview
2.1.1 Global Retinal Drugs and Biologics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Retinal Drugs and Biologics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Retinal Drugs and Biologics Market Competitive Landscape
3.1 Global Retinal Drugs and Biologics Sales by Manufacturers (2019-2024)
3.2 Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2019-2024)
3.3 Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Retinal Drugs and Biologics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Retinal Drugs and Biologics Sales Sites, Area Served, Product Type
3.6 Retinal Drugs and Biologics Market Competitive Situation and Trends
3.6.1 Retinal Drugs and Biologics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Retinal Drugs and Biologics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Retinal Drugs and Biologics Industry Chain Analysis
4.1 Retinal Drugs and Biologics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Retinal Drugs and Biologics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Retinal Drugs and Biologics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Retinal Drugs and Biologics Sales Market Share by Type (2019-2024)
6.3 Global Retinal Drugs and Biologics Market Size Market Share by Type (2019-2024)
6.4 Global Retinal Drugs and Biologics Price by Type (2019-2024)
7 Retinal Drugs and Biologics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Retinal Drugs and Biologics Market Sales by Application (2019-2024)
7.3 Global Retinal Drugs and Biologics Market Size (M USD) by Application (2019-2024)
7.4 Global Retinal Drugs and Biologics Sales Growth Rate by Application (2019-2024)
8 Retinal Drugs and Biologics Market Segmentation by Region
8.1 Global Retinal Drugs and Biologics Sales by Region
8.1.1 Global Retinal Drugs and Biologics Sales by Region
8.1.2 Global Retinal Drugs and Biologics Sales Market Share by Region
8.2 North America
8.2.1 North America Retinal Drugs and Biologics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Retinal Drugs and Biologics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Retinal Drugs and Biologics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Retinal Drugs and Biologics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Retinal Drugs and Biologics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 ALLERGAN
9.1.1 ALLERGAN Retinal Drugs and Biologics Basic Information
9.1.2 ALLERGAN Retinal Drugs and Biologics Product Overview
9.1.3 ALLERGAN Retinal Drugs and Biologics Product Market Performance
9.1.4 ALLERGAN Business Overview
9.1.5 ALLERGAN Retinal Drugs and Biologics SWOT Analysis
9.1.6 ALLERGAN Recent Developments
9.2 AbbVie
9.2.1 AbbVie Retinal Drugs and Biologics Basic Information
9.2.2 AbbVie Retinal Drugs and Biologics Product Overview
9.2.3 AbbVie Retinal Drugs and Biologics Product Market Performance
9.2.4 AbbVie Business Overview
9.2.5 AbbVie Retinal Drugs and Biologics SWOT Analysis
9.2.6 AbbVie Recent Developments
9.3 Alimera Sciences
9.3.1 Alimera Sciences Retinal Drugs and Biologics Basic Information
9.3.2 Alimera Sciences Retinal Drugs and Biologics Product Overview
9.3.3 Alimera Sciences Retinal Drugs and Biologics Product Market Performance
9.3.4 Alimera Sciences Retinal Drugs and Biologics SWOT Analysis
9.3.5 Alimera Sciences Business Overview
9.3.6 Alimera Sciences Recent Developments
9.4 Janssen Biotech
9.4.1 Janssen Biotech Retinal Drugs and Biologics Basic Information
9.4.2 Janssen Biotech Retinal Drugs and Biologics Product Overview
9.4.3 Janssen Biotech Retinal Drugs and Biologics Product Market Performance
9.4.4 Janssen Biotech Business Overview
9.4.5 Janssen Biotech Recent Developments
9.5 Swedish Orphan Biovitrum
9.5.1 Swedish Orphan Biovitrum Retinal Drugs and Biologics Basic Information
9.5.2 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Overview
9.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Market Performance
9.5.4 Swedish Orphan Biovitrum Business Overview
9.5.5 Swedish Orphan Biovitrum Recent Developments
9.6 Roche
9.6.1 Roche Retinal Drugs and Biologics Basic Information
9.6.2 Roche Retinal Drugs and Biologics Product Overview
9.6.3 Roche Retinal Drugs and Biologics Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Bristol-Myers Squibb
9.7.1 Bristol-Myers Squibb Retinal Drugs and Biologics Basic Information
9.7.2 Bristol-Myers Squibb Retinal Drugs and Biologics Product Overview
9.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Product Market Performance
9.7.4 Bristol-Myers Squibb Business Overview
9.7.5 Bristol-Myers Squibb Recent Developments
9.8 Genzyme
9.8.1 Genzyme Retinal Drugs and Biologics Basic Information
9.8.2 Genzyme Retinal Drugs and Biologics Product Overview
9.8.3 Genzyme Retinal Drugs and Biologics Product Market Performance
9.8.4 Genzyme Business Overview
9.8.5 Genzyme Recent Developments
9.9 Genentech
9.9.1 Genentech Retinal Drugs and Biologics Basic Information
9.9.2 Genentech Retinal Drugs and Biologics Product Overview
9.9.3 Genentech Retinal Drugs and Biologics Product Market Performance
9.9.4 Genentech Business Overview
9.9.5 Genentech Recent Developments
9.10 OCULAR THERAPEUTIX
9.10.1 OCULAR THERAPEUTIX Retinal Drugs and Biologics Basic Information
9.10.2 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Overview
9.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Market Performance
9.10.4 OCULAR THERAPEUTIX Business Overview
9.10.5 OCULAR THERAPEUTIX Recent Developments
9.11 Bausch and Lomb
9.11.1 Bausch and Lomb Retinal Drugs and Biologics Basic Information
9.11.2 Bausch and Lomb Retinal Drugs and Biologics Product Overview
9.11.3 Bausch and Lomb Retinal Drugs and Biologics Product Market Performance
9.11.4 Bausch and Lomb Business Overview
9.11.5 Bausch and Lomb Recent Developments
9.12 UCBCares
9.12.1 UCBCares Retinal Drugs and Biologics Basic Information
9.12.2 UCBCares Retinal Drugs and Biologics Product Overview
9.12.3 UCBCares Retinal Drugs and Biologics Product Market Performance
9.12.4 UCBCares Business Overview
9.12.5 UCBCares Recent Developments
10 Retinal Drugs and Biologics Market Forecast by Region
10.1 Global Retinal Drugs and Biologics Market Size Forecast
10.2 Global Retinal Drugs and Biologics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Retinal Drugs and Biologics Market Size Forecast by Country
10.2.3 Asia Pacific Retinal Drugs and Biologics Market Size Forecast by Region
10.2.4 South America Retinal Drugs and Biologics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Retinal Drugs and Biologics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Retinal Drugs and Biologics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Retinal Drugs and Biologics by Type (2025-2030)
11.1.2 Global Retinal Drugs and Biologics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Retinal Drugs and Biologics by Type (2025-2030)
11.2 Global Retinal Drugs and Biologics Market Forecast by Application (2025-2030)
11.2.1 Global Retinal Drugs and Biologics Sales (Kilotons) Forecast by Application
11.2.2 Global Retinal Drugs and Biologics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
